ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Clinical Practice Session

Iron, Erythropoietin, and Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in CKD and ESKD

October 24, 2024 | 10:30 AM - 12:30 PM

Location: Ballroom 20D, Convention Center

Session Description

Anemia is a frequent complication in patients with kidney diseases. This session discusses iron deficiency anemia, including effects of iron deficiency on nonhematologic organ systems. The pharmacology of various preparations of iron-replenishing agents and erythropoietin-stimulating agents is compared and contrasted. The novel class of agents, hypoxia-inducible factor-prolyl hydroxylase inhibitors, is discussed with suggestions for how to incorporate them into clinical practice.

Learning Objective(s)

  • Summarize potential adverse effects of iron deficiency on nonhematologic organ systems
  • Distinguish clinically available iron replacement and erythropoietin-stimulating agent formulations
  • Appraise the role of hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia in patients with kidney diseases

Learning Pathway(s)

  • CKD Non-Dialysis
  • Dialysis

Moderators

Presentations